Elevai Labs, Inc. (NASDAQ:ELAB – Get Free Report) saw a large growth in short interest in April. As of April 15th, there was short interest totalling 54,800 shares, a growth of 66.1% from the March 31st total of 33,000 shares. Based on an average daily volume of 662,400 shares, the short-interest ratio is presently 0.1 days.
Elevai Labs Trading Down 2.2 %
ELAB stock opened at $0.66 on Friday. Elevai Labs has a 1 year low of $0.57 and a 1 year high of $4.24. The firm has a 50-day moving average of $0.69.
Elevai Labs (NASDAQ:ELAB – Get Free Report) last released its quarterly earnings results on Friday, March 29th. The company reported ($0.08) earnings per share (EPS) for the quarter. The company had revenue of $0.70 million during the quarter.
Elevai Labs Company Profile
Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021.
Further Reading
- Five stocks we like better than Elevai Labs
- Insider Trades May Not Tell You What You Think
- 3 Stocks Leading the U.S. Agriculture Comeback
- What Does a Stock Split Mean?
- How to Use Put Debit Spreads to Profit From Falling Stocks
- How to Calculate Options Profits
- Alphabet Changes the Narrative with Its First-Ever Dividend
Receive News & Ratings for Elevai Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elevai Labs and related companies with MarketBeat.com's FREE daily email newsletter.
